Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CATB | OCUP | ACXP | ||
Company | Catabasis Pharma | Ocuphire Pharma Inc | Acurx Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.21 | 1.3200 | 2.03 | ||
High | 9.21 | 1.3700 | 2.03 | ||
Low | 8.46 | 1.3200 | 1.92 | ||
Last | 8.54 | 1.3300 | 1.97 | ||
Change | -0.64 | +0.0200 | -0.05 | ||
% Change | -6.97% | +1.53% | -2.48% | ||
Volume | 98,800 | 89,400 | 57,200 | ||
20-Day Average Volume | 395,311 | 98,015 | 57,190 | ||
Previous Close | 9.18 | 1.3100 | 2.02 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 8.72 | 1.2655 | 2.11 | ||
20-Day Raw Stochastic | 56.46% | 66.67% | 17.65% | ||
20-Day Relative Strength | 43.24% | 45.14% | 42.87% | ||
Weighted Alpha | -50.43 | -68.02 | -19.96 | ||
Today's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
Previous Opinion | 72% Sell | 88% Sell | 100% Sell | ||
Last Month's Opinion | 100% Sell | 88% Sell | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -14.34% since 08/31/21 | +2.31% since 09/11/24 | -1.01% since 09/11/24 | ||
Low | 8.46 on 09/08/21 | 1.2300 on 09/12/24 | 1.92 on 09/18/24 | ||
High | 10.26 on 09/02/21 | 1.3700 on 09/18/24 | 2.08 on 09/13/24 | ||
1-Month | |||||
%Chg | -8.17% since 08/06/21 | unch since 08/16/24 | -1.99% since 08/16/24 | ||
Low | 6.31 on 08/20/21 | 1.1500 on 09/04/24 | 1.88 on 09/06/24 | ||
High | 10.26 on 09/02/21 | 1.4200 on 08/21/24 | 2.39 on 08/22/24 | ||
3-Month | |||||
%Chg | -34.10% since 06/08/21 | -13.07% since 06/18/24 | -12.44% since 06/18/24 | ||
Low | 6.31 on 08/20/21 | 1.1500 on 09/04/24 | 1.72 on 08/09/24 | ||
High | 15.72 on 06/16/21 | 2.1800 on 07/18/24 | 3.33 on 07/18/24 | ||
6-Month | |||||
%Chg | -50.23% since 03/08/21 | -31.09% since 03/18/24 | -23.94% since 03/18/24 | ||
Low | 6.31 on 08/20/21 | 1.1500 on 09/04/24 | 1.52 on 04/16/24 | ||
High | 22.01 on 03/18/21 | 2.3400 on 04/02/24 | 3.33 on 07/18/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 33,337 | 33,960 | 32,003 | ||
Shares Outstanding, K | 3,904 | 25,924 | 15,843 | ||
Annual Sales | 0 | 19,050,000 | 0 | ||
Annual Net Income | -37,300,000 | -9,990,000 | -14,580,000 | ||
Last Quarter Sales | 0 | 1,110,000 | 0 | ||
Last Quarter Net Income | -7,470,000 | -7,770,000 | -4,120,000 | ||
60-Month Beta | 1.66 | 0.20 | -1.72 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.30 on 08/13/24 | -0.26 on 08/09/24 | ||
Latest Earnings Date | 08/09/21 | 11/11/24 | 11/11/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |